{"id":8785,"date":"2026-02-27T10:42:21","date_gmt":"2026-02-27T09:42:21","guid":{"rendered":"https:\/\/www.msd.ch\/en\/?page_id=8785"},"modified":"2026-02-27T10:42:30","modified_gmt":"2026-02-27T09:42:30","slug":"winrevair-publication-of-clinical-trial-results","status":"publish","type":"page","link":"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/","title":{"rendered":"WINREVAIR\u00ae &#8211; Publication of clinical trial results"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">Publication of clinical trial results<\/h1>\n\n\n\n<p>The information given below and the relevant links to the clinical data fulfil the requirements of Articles 71-73 of the Ordinance on Therapeutic Products (Therapeutic Products Ordinance, TPO). They supplement the information published in association with the Swiss marketing authorisation for the medicinal product.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">WINREVAIR\u00ae<\/h2>\n\n\n\n<p>Winrevair\u00ae (Sotatercept), powder for solution for injection, 45 mg or 60 mg Sotatercept per vial.<\/p>\n\n\n\n<p>Authorisation number: 69787<\/p>\n\n\n\n<p>Swissmedic authorisation date: 16 October 2024<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><br>Pivotal Trials:<\/h4>\n\n\n\n<p>PULSAR &#8211; NCT03496207: <a href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2017-004738-27\/results\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">EudraCT Number 2017-004738-27 &#8211; Clinical trial results &#8211; EU Clinical Trials Register<\/a><\/p>\n\n\n\n<p>STELLAR \u2013 NCT04576988: <a href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-004142-11\/results#resultContent\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">EudraCT Number 2020-004142-11 &#8211; Clinical trial results &#8211; EU Clinical Trials Register<\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Publications:<\/h4>\n\n\n\n<p>Humbert M, et al. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2021;384(13):1204-1215. DOI: 10.1056\/NEJMoa2024277.<\/p>\n\n\n\n<p>Hoeper MM et al. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med;2023;388(16):1478-1490. DOI: 10.1056\/NEJMoa2213558.<\/p>\n\n\n\n<p><sup>CH-SOT-00102, 02\/2026<\/sup><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Publication of clinical trial results The information given below and the relevant links to the clinical data fulfil the requirements of Articles 71-73 of the Ordinance on Therapeutic Products (Therapeutic Products Ordinance, TPO). They supplement the information published in association with the Swiss marketing authorisation for the medicinal product. WINREVAIR\u00ae Winrevair\u00ae (Sotatercept), powder for solution [&hellip;]<\/p>\n","protected":false},"author":974,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"editor_notices":[],"footnotes":""},"class_list":["post-8785","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.9.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>WINREVAIR\u00ae - Publication of clinical trial results - msd.ch<\/title>\n<meta name=\"description\" content=\"Publication of clinical trial results of WINREVAIR, which has been authorised by Swissmedic on 13 September 2024.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WINREVAIR\u00ae - Publication of clinical trial results - msd.ch\" \/>\n<meta property=\"og:description\" content=\"Publication of clinical trial results of WINREVAIR, which has been authorised by Swissmedic on 13 September 2024.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"msd.ch\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-27T09:42:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/\",\"url\":\"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/\",\"name\":\"WINREVAIR\u00ae - Publication of clinical trial results - msd.ch\",\"isPartOf\":{\"@id\":\"https:\/\/www.msd.ch\/en\/#website\"},\"datePublished\":\"2026-02-27T09:42:21+00:00\",\"dateModified\":\"2026-02-27T09:42:30+00:00\",\"description\":\"Publication of clinical trial results of WINREVAIR, which has been authorised by Swissmedic on 13 September 2024.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.msd.ch\/en\/#website\",\"url\":\"https:\/\/www.msd.ch\/en\/\",\"name\":\"msd.ch\",\"description\":\"MSD researches and develops medicines and vaccines to save lives and improve patients&#039; health. In Switzerland, 1000 employees in Lucerne and Zurich are dedicated to this.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.msd.ch\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WINREVAIR\u00ae - Publication of clinical trial results - msd.ch","description":"Publication of clinical trial results of WINREVAIR, which has been authorised by Swissmedic on 13 September 2024.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/","og_locale":"en_US","og_type":"article","og_title":"WINREVAIR\u00ae - Publication of clinical trial results - msd.ch","og_description":"Publication of clinical trial results of WINREVAIR, which has been authorised by Swissmedic on 13 September 2024.","og_url":"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/","og_site_name":"msd.ch","article_modified_time":"2026-02-27T09:42:30+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/","url":"https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/","name":"WINREVAIR\u00ae - Publication of clinical trial results - msd.ch","isPartOf":{"@id":"https:\/\/www.msd.ch\/en\/#website"},"datePublished":"2026-02-27T09:42:21+00:00","dateModified":"2026-02-27T09:42:30+00:00","description":"Publication of clinical trial results of WINREVAIR, which has been authorised by Swissmedic on 13 September 2024.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.msd.ch\/en\/winrevair-publication-of-clinical-trial-results\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.msd.ch\/en\/#website","url":"https:\/\/www.msd.ch\/en\/","name":"msd.ch","description":"MSD researches and develops medicines and vaccines to save lives and improve patients&#039; health. In Switzerland, 1000 employees in Lucerne and Zurich are dedicated to this.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.msd.ch\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/pages\/8785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/users\/974"}],"replies":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/comments?post=8785"}],"version-history":[{"count":4,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/pages\/8785\/revisions"}],"predecessor-version":[{"id":10311,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/pages\/8785\/revisions\/10311"}],"wp:attachment":[{"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/media?parent=8785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}